13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060321
Total Value
$133.9M
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,629,464 | $14.2M | 10.61% |
| 2 | CRINETICS PHARMACEUTICALS IN | CRNX | 741,043 | $11.9M | 8.89% |
| 3 | CHINOOK THERAPEUTICS INC | 16961L106 | 506,818 | $11.7M | 8.76% |
| 4 | HORIZON THERAPEUTICS PLC | G46188101 | 99,217 | $10.8M | 8.09% |
| 5 | BIOGEN INC(NSM) | BIIB | 37,459 | $10.4M | 7.78% |
| 6 | CYTOKINETICS INC | CYTK | 282,886 | $10.0M | 7.44% |
| 7 | BIOCRYST PHARMACEUTICALS INC | BCRX | 1,163,535 | $9.7M | 7.25% |
| 8 | MORPHIC HOLDING INC | 61775R105 | 246,616 | $9.3M | 6.93% |
| 9 | KALVISTA PHARMACEUTICALS INC | KALV | 1,121,982 | $8.8M | 6.59% |
| 10 | ASCENDIS PHARMA A/S - ADR | ASND | 77,210 | $8.3M | 6.18% |
| 11 | APELLIS PHARMACEUTICALS INC | APLS | 123,165 | $8.1M | 6.07% |
| 12 | ITEOS THERAPEUTICS INC | 46565G104 | 480,653 | $6.5M | 4.89% |
| 13 | SAGE THERAPEUTICS INC | 78667J108 | 145,018 | $6.1M | 4.54% |
| 14 | AMICUS THERAPEUTICS INC(NMS) | FOLD | 258,288 | $2.9M | 2.14% |
| 15 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 178,217 | $2.0M | 1.46% |
| 16 | 2SEVENTY BIO INC | 901384107 | 172,188 | $1.8M | 1.31% |
| 17 | ASTRIA THERAPEUTICS INC | 04635X102 | 101,339 | $1.3M | 1.01% |
| 18 | SCILEX HOLDING CO(NAS) | SCLXW | 10,390 | $85,198 | 0.06% |